Merck (MRK) Total Liabilities (2009 - 2026)

Merck (MRK) has 18 years of Total Liabilities data on file, last reported at $82.8 billion in Q1 2026.

• Total Liabilities for Q1 2026 came in at $82.8 billion, up 24.03% year-over-year; the trailing twelve-month figure through Mar 2026 was $82.8 billion (up 24.03% YoY), and the FY2025 annual result was $84.3 billion, up 84160.0% from the prior year.
• Total Liabilities fell to $82.8 billion in Q1 2026 per MRK's latest filing, from $84.3 billion in the prior quarter.
• Over five years, Total Liabilities peaked at $84.3 billion in Q4 2025 and troughed at $100.0 million in Q4 2024.
• A 5-year average of $42.1 billion and a median of $63.8 billion in 2022 frame the typical range for Total Liabilities.
• The sharpest annual moves came in 2023 and 2025: Total Liabilities tumbled 99.6% in 2023, then jumped 84160.0% in 2025.
• A 5-year view of Total Liabilities shows it stood at $600.0 million in 2022, then slumped by 58.33% to $250.0 million in 2023, then sank by 60.0% to $100.0 million in 2024, then jumped by 84160.0% to $84.3 billion in 2025, then slipped by 1.79% to $82.8 billion in 2026.
• Business Quant data shows MRK's Total Liabilities at $82.8 billion in Q1 2026, $84.3 billion in Q4 2025, and $77.6 billion in Q3 2025.